Clinical trial
Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
NCT00348686 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00348686 |
|---|---|
| Title | Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) |
| Official title | A Multicenter, Non-comparative, Phase IV Study to Evaluate the Effect of Candesartan Based Therapy in the Percent Change of proBNP Level After 24 Week Treatment in the Patients With Hypertension With Left Ventricular Hypertrophy |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Left Ventricular Hypertrophy |
| Intervention type | Drug |
| Interventions | Candesartan, Felodipine |
| Enrollment | 315 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 6, 2006 |
| Last update posted | Apr 2, 2012 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: